The watchdog's mandate allows it to block deals that would likely result in a substantial lessening of competition.
($1 = $1.0391 Canadian)
(Reporting by Alastair Sharp; Editing by Jeffrey Hodgson)
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
156.7 CAD | -0.22% | +0.43% | +22.22% |
03:11pm | Loblaw Ratings Confirmed at DBRS | MT |
05-16 | Loblaw Announces Support For Revised Grocery Code of Conduct; But Reports Note Walmart Canada Still An Outlier | MT |
TORONTO (Reuters) - Canada's Competition Bureau said on Monday it will review Loblaw's proposed C$12.4 billion ($11.9 billion) acquisition of Shoppers Drug Mart, and that it was difficult to say how long the review would take.
The watchdog's mandate allows it to block deals that would likely result in a substantial lessening of competition.
($1 = $1.0391 Canadian)
(Reporting by Alastair Sharp; Editing by Jeffrey Hodgson)
1st Jan change | Capi. | |
---|---|---|
+22.22% | 35.22B | |
+22.65% | 516B | |
+18.40% | 39.61B | |
+3.54% | 37.97B | |
+12.70% | 30B | |
+6.92% | 27.08B | |
-14.92% | 25.97B | |
+15.65% | 18.75B | |
+4.86% | 18.14B | |
+5.80% | 14.71B |